Phibro Animal Health (PAHC) Competitors $26.11 -0.39 (-1.47%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$26.12 +0.02 (+0.06%) As of 08/1/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAHC vs. PCVX, MRUS, CYTK, RNA, ADMA, KRYS, MTSR, ABVX, ZLAB, and AKROShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Vaxcyte (PCVX), Merus (MRUS), Cytokinetics (CYTK), Avidity Biosciences (RNA), ADMA Biologics (ADMA), Krystal Biotech (KRYS), Metsera (MTSR), Abivax (ABVX), Zai Lab (ZLAB), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. Its Competitors Vaxcyte Merus Cytokinetics Avidity Biosciences ADMA Biologics Krystal Biotech Metsera Abivax Zai Lab Akero Therapeutics Phibro Animal Health (NASDAQ:PAHC) and Vaxcyte (NASDAQ:PCVX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations. Does the media refer more to PAHC or PCVX? In the previous week, Vaxcyte had 4 more articles in the media than Phibro Animal Health. MarketBeat recorded 8 mentions for Vaxcyte and 4 mentions for Phibro Animal Health. Vaxcyte's average media sentiment score of 1.34 beat Phibro Animal Health's score of 1.17 indicating that Vaxcyte is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vaxcyte 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, PAHC or PCVX? Phibro Animal Health has higher revenue and earnings than Vaxcyte. Vaxcyte is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.02B1.04$2.42M$0.7833.47VaxcyteN/AN/A-$463.93M-$3.99-8.28 Is PAHC or PCVX more profitable? Phibro Animal Health has a net margin of 2.68% compared to Vaxcyte's net margin of 0.00%. Phibro Animal Health's return on equity of 30.51% beat Vaxcyte's return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health2.68% 30.51% 6.89% Vaxcyte N/A -17.12%-16.26% Do analysts recommend PAHC or PCVX? Phibro Animal Health presently has a consensus price target of $24.40, suggesting a potential downside of 6.55%. Vaxcyte has a consensus price target of $136.50, suggesting a potential upside of 313.39%. Given Vaxcyte's stronger consensus rating and higher possible upside, analysts plainly believe Vaxcyte is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.83Vaxcyte 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.10 Which has more risk and volatility, PAHC or PCVX? Phibro Animal Health has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Vaxcyte has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Do institutionals & insiders have more ownership in PAHC or PCVX? 99.3% of Phibro Animal Health shares are held by institutional investors. Comparatively, 96.8% of Vaxcyte shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 3.1% of Vaxcyte shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryPhibro Animal Health beats Vaxcyte on 9 of the 16 factors compared between the two stocks. Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07B$10.40B$5.48B$9.51BDividend Yield1.81%1.99%4.73%4.09%P/E Ratio33.4718.4228.6723.80Price / Sales1.0429.01373.9066.58Price / Cash12.5422.3135.4557.96Price / Book4.123.478.275.55Net Income$2.42M$234.77M$3.24B$259.03M7 Day Performance-10.52%-4.82%-3.69%-4.59%1 Month Performance-6.55%1.80%4.33%4.46%1 Year Performance47.18%-12.51%25.95%18.03% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health4.1332 of 5 stars$26.11-1.5%$24.40-6.5%+41.1%$1.07B$1.02B33.471,940Positive NewsDividend AnnouncementPCVXVaxcyte2.2389 of 5 stars$35.87-2.1%$136.50+280.5%-58.0%$4.73BN/A-8.99160News CoveragePositive NewsUpcoming EarningsMRUSMerus2.9208 of 5 stars$65.59-1.8%$86.40+31.7%+25.1%$4.62B$36.13M-16.0837News CoverageCYTKCytokinetics4.0154 of 5 stars$36.63-1.5%$70.92+93.6%-36.6%$4.44B$19.22M-6.92250News CoverageUpcoming EarningsAnalyst ForecastInsider TradeRNAAvidity Biosciences2.7815 of 5 stars$34.56-4.7%$66.35+92.0%-19.4%$4.37B$10.90M-11.52190News CoverageUpcoming EarningsADMAADMA Biologics4.2926 of 5 stars$18.00-0.1%$27.67+53.7%+57.7%$4.30B$426.45M21.18530Upcoming EarningsKRYSKrystal Biotech4.8885 of 5 stars$152.91+3.6%$211.33+38.2%-21.0%$4.27B$290.52M36.76210Upcoming EarningsMTSRMetseraN/A$39.43-2.6%$55.00+39.5%N/A$4.25BN/A0.0081News CoverageEarnings ReportLockup ExpirationAnalyst RevisionGap UpABVXAbivax3.6107 of 5 stars$66.57+0.1%$85.33+28.2%+511.7%$4.22BN/A0.0061News CoverageAnalyst ForecastGap DownZLABZai Lab2.217 of 5 stars$38.69+4.1%$54.28+40.3%+99.7%$4.13B$398.99M-15.541,869News CoveragePositive NewsUpcoming EarningsShort Interest ↑Gap UpAKROAkero Therapeutics3.9641 of 5 stars$49.24-2.6%$82.50+67.5%+83.6%$4.03BN/A-25.2530Positive NewsUpcoming Earnings Related Companies and Tools Related Companies PCVX Competitors MRUS Competitors CYTK Competitors RNA Competitors ADMA Competitors KRYS Competitors MTSR Competitors ABVX Competitors ZLAB Competitors AKRO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAHC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PAHC Stock Alerts